Alessandro D. Santin, MD, is an oncologist who cares for patients with endometrial and other gynecologic cancers. He is experienced with intraperitoneal chemotherapy, which is given through the abdomen to treat ovarian cancer. Dr. Santin has treated patients from throughout Connecticut and beyond who have been diagnosed with uterine serous carcinoma (USC), a highly aggressive and chemotherapy-resistant disease.
A professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine, Dr. Santin is a clinical research program leader for the Yale Medicine Section of Gynecologic Cancers. He writes extensively on cancers of the ovary, endometrium and cervix, as well as tumor immunology and immunotherapy. “In addition to a number of well-known cancer genes, we identified three genes that had not previously been associated with cancer,” he says. “These are pathways that could be important tools in developing therapies down the road.” He focuses
part of his research on testing novel immunotherapeutic strategies as potential treatment options.
Dr. Santin has been recognized as one of the Top Doctors in the state by Castle Connolly Medical Ltd., which provides Connecticut Magazine’s annual list.